Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19

Objective The coronavirus disease 2019 (COVID-19) pandemic has reduced the demand for, and supply of, head and neck cancer services. This study compares the times to diagnosis, staging, and treatment of head and neck cancers before and during the COVID-19 pandemic. Study Design Retrospective cohort...

Full description

Bibliographic Details
Main Authors: Peter Yao, Victoria Cooley MS, William Kuhel MD, Andrew Tassler MD, Victoria Banuchi MD, Sallie Long MD, Oleksandr Savenkov PhD, David Ivan Kutler MD
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:OTO Open
Online Access:https://doi.org/10.1177/2473974X211059429
_version_ 1797641302587736064
author Peter Yao
Victoria Cooley MS
William Kuhel MD
Andrew Tassler MD
Victoria Banuchi MD
Sallie Long MD
Oleksandr Savenkov PhD
David Ivan Kutler MD
author_facet Peter Yao
Victoria Cooley MS
William Kuhel MD
Andrew Tassler MD
Victoria Banuchi MD
Sallie Long MD
Oleksandr Savenkov PhD
David Ivan Kutler MD
author_sort Peter Yao
collection DOAJ
description Objective The coronavirus disease 2019 (COVID-19) pandemic has reduced the demand for, and supply of, head and neck cancer services. This study compares the times to diagnosis, staging, and treatment of head and neck cancers before and during the COVID-19 pandemic. Study Design Retrospective cohort study. Setting Tertiary academic medical center in New York City (NYC). Methods The times to diagnosis, staging, and treatment of head and neck cancer for patients presenting to the clinics of 4 head and neck oncology surgeons with newly diagnosed head and neck cancers were compared between pre–COVID-19 and COVID-19 periods. Results Sixty-eight patients in the pre–COVID-19 period and 26 patients in the COVID-19 period presented with newly diagnosed head and neck cancer. Patients in the COVID-19 group had a significantly longer time to diagnosis than the pre–COVID-19 group after adjustment for age and cancer diagnosis ( P = .02; hazard ratio [HR], 0.54; 95% CI, 0.32-0.92). Patients in the pre–COVID-19 and COVID-19 groups had no statistically significant differences in time to staging ( P > .9; HR, 1.01; 95% CI, 0.58-1.74) or time to treatment ( P = .12; HR, 1.55; 95% CI, 0.89-2.72). Conclusion This study found that time to diagnosis for head and neck cancers was delayed during a COVID-19 period compared to a pre–COVID-19 period. However, there was no evidence of delays in time to staging and time to treatment during the COVID-19 period. Our results prompt further investigations into the factors contributing to diagnostic delays but provide reassurance that despite COVID-19, patients were receiving timely staging and treatment for head and neck cancers.
first_indexed 2024-03-11T13:43:38Z
format Article
id doaj.art-c9c3cc9770f14dfcac1571ce8e716c28
institution Directory Open Access Journal
issn 2473-974X
language English
last_indexed 2024-03-11T13:43:38Z
publishDate 2021-11-01
publisher Wiley
record_format Article
series OTO Open
spelling doaj.art-c9c3cc9770f14dfcac1571ce8e716c282023-11-02T11:18:22ZengWileyOTO Open2473-974X2021-11-01510.1177/2473974X211059429Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19Peter Yao0Victoria Cooley MS1William Kuhel MD2Andrew Tassler MD3Victoria Banuchi MD4Sallie Long MD5Oleksandr Savenkov PhD6David Ivan Kutler MD7Weill Cornell Medical College, Weill Cornell Medicine, New York, New York, USADepartment of Population Health Sciences, Weill Cornell Medicine, New York, New York, USADepartment of Otolaryngology-Head and Neck Surgery, Weill Cornell Medicine, New York, New York, USADepartment of Otolaryngology-Head and Neck Surgery, Weill Cornell Medicine, New York, New York, USADepartment of Otolaryngology-Head and Neck Surgery, Weill Cornell Medicine, New York, New York, USADepartment of Otolaryngology-Head and Neck Surgery, Weill Cornell Medicine, New York, New York, USADepartment of Population Health Sciences, Weill Cornell Medicine, New York, New York, USADepartment of Otolaryngology-Head and Neck Surgery, Weill Cornell Medicine, New York, New York, USAObjective The coronavirus disease 2019 (COVID-19) pandemic has reduced the demand for, and supply of, head and neck cancer services. This study compares the times to diagnosis, staging, and treatment of head and neck cancers before and during the COVID-19 pandemic. Study Design Retrospective cohort study. Setting Tertiary academic medical center in New York City (NYC). Methods The times to diagnosis, staging, and treatment of head and neck cancer for patients presenting to the clinics of 4 head and neck oncology surgeons with newly diagnosed head and neck cancers were compared between pre–COVID-19 and COVID-19 periods. Results Sixty-eight patients in the pre–COVID-19 period and 26 patients in the COVID-19 period presented with newly diagnosed head and neck cancer. Patients in the COVID-19 group had a significantly longer time to diagnosis than the pre–COVID-19 group after adjustment for age and cancer diagnosis ( P = .02; hazard ratio [HR], 0.54; 95% CI, 0.32-0.92). Patients in the pre–COVID-19 and COVID-19 groups had no statistically significant differences in time to staging ( P > .9; HR, 1.01; 95% CI, 0.58-1.74) or time to treatment ( P = .12; HR, 1.55; 95% CI, 0.89-2.72). Conclusion This study found that time to diagnosis for head and neck cancers was delayed during a COVID-19 period compared to a pre–COVID-19 period. However, there was no evidence of delays in time to staging and time to treatment during the COVID-19 period. Our results prompt further investigations into the factors contributing to diagnostic delays but provide reassurance that despite COVID-19, patients were receiving timely staging and treatment for head and neck cancers.https://doi.org/10.1177/2473974X211059429
spellingShingle Peter Yao
Victoria Cooley MS
William Kuhel MD
Andrew Tassler MD
Victoria Banuchi MD
Sallie Long MD
Oleksandr Savenkov PhD
David Ivan Kutler MD
Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19
OTO Open
title Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19
title_full Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19
title_fullStr Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19
title_full_unstemmed Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19
title_short Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19
title_sort times to diagnosis staging and treatment of head and neck cancer before and during covid 19
url https://doi.org/10.1177/2473974X211059429
work_keys_str_mv AT peteryao timestodiagnosisstagingandtreatmentofheadandneckcancerbeforeandduringcovid19
AT victoriacooleyms timestodiagnosisstagingandtreatmentofheadandneckcancerbeforeandduringcovid19
AT williamkuhelmd timestodiagnosisstagingandtreatmentofheadandneckcancerbeforeandduringcovid19
AT andrewtasslermd timestodiagnosisstagingandtreatmentofheadandneckcancerbeforeandduringcovid19
AT victoriabanuchimd timestodiagnosisstagingandtreatmentofheadandneckcancerbeforeandduringcovid19
AT sallielongmd timestodiagnosisstagingandtreatmentofheadandneckcancerbeforeandduringcovid19
AT oleksandrsavenkovphd timestodiagnosisstagingandtreatmentofheadandneckcancerbeforeandduringcovid19
AT davidivankutlermd timestodiagnosisstagingandtreatmentofheadandneckcancerbeforeandduringcovid19